Antonio Costanzo

Curaleaf International has appointed Miles Worne as president. Antonio Costanzo, the company’s former CEO, will remain with the company in a consultancy capacity, with his role transitioning to focus on M&A and regulatory affairs. Miles Worne has significant experience in building...

Curaleaf International's (OTCQX: CURLF) Medalchemy, GMP certified manufacturing site in Alicante, Spain has received approval from the Spanish Health Authorities to begin operating out of its newly built extract manufacturing site and microbiological testing laboratory. This approval coincides...

Curaleaf International, a division of Curaleaf Holdings (OTCQX: CURLF) (CNSX:CURA), announced the successful license of the company’s range of cannabis based medicines as extract, under the name Adven, in Malta. The product range is being manufactured to meet the growing demand for medical...

Europeans are becoming more open to embracing cannabis legalization, according to new polling data released by Hanway Associates and reported by Curaleaf International, one of the vertically integrated marijuana companies in Europe.  The data revealed that the...

Curaleaf International (formerly EMMAC Life Sciences Group) part of vertically integrated cannabis company Curaleaf Holdings (CNSX: CURA) (OTCQX: CURLF) announced Monday its official rebrand to the European market.  The company’s cannabis flower and...

Europe-based vertically integrated cannabis company Curaleaf International is introducing a second range of medical cannabis flower products for the U.K. market. The move follows the successful export of over one metric ton of medical cannabis to Israel as part of a larger supply deal with BOL...

Vertically integrated cannabis company Curaleaf International announced Thursday it has successfully exported more than one metric ton of medical cannabis to Israel as part of a larger supply deal with BOL Pharma. The move follows the company's recent announcement that its's subsidiary...

As Curaleaf International's subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa, with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological...

Curaleaf International's subsidiary, Adven GmbH, recently introduced its medical cannabis products in Germany, Europe's largest medical cannabis market. Massacussets-based Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) purchased EMMAC Life Sciences – now operating as Curaleaf...